References: 1. Approved cellular and gene therapy products. US Food and Drug Administration website. Updated June 23, 2022. Accessed August 4, 2022. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products. 2. Ferrari G, Thrasher AJ, Aiuti A. Gene therapy using haematopoietic stem and progenitor cells. Nat Rev Genet. 2021;22(4):216-234. doi:10.1038/s41576-020-00298-5. 3. Leonard A, Sharma A, Uchida N, et al. Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease. Blood Adv. 2021;5(9):2403-2411. doi:10.1182/bloodadvances.2021004232. 4. Yannaki E, Karponi G, Zervou F, et al. Hematopoietic stem cell mobilization for gene therapy: superior mobilization by the combination of granulocyte–colony stimulating factor plus plerixafor in patients with β-thalassemia major. Hum Gene Ther. 2013;24(10):852-860. doi:10.1089/hum.2013.163. 5. Soofiyani SR, Baradaran B, Lotfipour F, Kazemi T, Mohammadnejad L. Gene therapy, early promises, subsequent problems, and recent breakthroughs. Adv Pharm Bull. 2013;3(2):249-255. doi:10.5681/apb.2013.041. 6. Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, et al. Current clinical applications of in vivo gene therapy with AAVs. Mol Ther. 2021;29(2):464-488. doi:10.1016/j.ymthe.2020.12.007. 7. Donating stem cells and bone marrow. American Cancer Society website. Revised August 4, 2020. Accessed August 4, 2022. https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/donors.html. 8. Genetic therapy conditioning: patient guide. Cure Sickle Cell website. Accessed August 4, 2022. https://curesickle.org/system/files/CSC_Conditioning_Patient_Bi_FOLD_FactSheet_042321_Digital_CenterSpread.pdf. 9. Colella P, Ronzitti G, Mingozzi F. Emerging issues in AAV-mediated in vivo gene therapy. Mol Ther Methods Clin Dev. 2018;8:87-104. doi:10.1016/j.omtm.2017.11.007. 10. Goswami R, Subramanian G, Silayeva L, et al. Gene therapy leaves a vicious cycle. Front Oncol. 2019;9:297. doi:10.3389/fonc.2019.00297. 11. Sinclair A, Islam S, Jones S. Gene therapy: an overview of approved and pipeline technologies. In: CADTH Issues in Emerging Health Technologies. Canadian Agency for Drugs and Technologies in Health; 2016-. Published March 1, 2018. Accessed August 4, 2022. https://www.ncbi.nlm.nih.gov/books/NBK538378. 12. US Department of Health and Human Services, Food and Drug Administration, and Center for Biologics Evaluation and Research. Long term follow-up after administration of human gene therapy products. Published January 2020. Accessed August 4, 2022. https://www.fda.gov/media/113768/download. 13. National Academies of Sciences, Engineering, and Medicine. Exploring novel clinical trial designs for gene-based therapies: proceedings of a workshop. Published 2020. Accessed August 4, 2022. doi:10.17226/25712.